ar-c239 has been researched along with phenylephrine in 2 studies
| Studies (ar-c239) | Trials (ar-c239) | Recent Studies (post-2010) (ar-c239) | Studies (phenylephrine) | Trials (phenylephrine) | Recent Studies (post-2010) (phenylephrine) |
|---|---|---|---|---|---|
| 45 | 0 | 5 | 13,797 | 857 | 2,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chotani, MA; Daunt, D; Flavahan, NA; Flavahan, S; Mitra, S | 1 |
| Hopwood, SE; Stamford, JA | 1 |
2 other study(ies) available for ar-c239 and phenylephrine
| Article | Year |
|---|---|
Silent alpha(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arteries; Body Temperature Regulation; Brimonidine Tartrate; Cold Temperature; COS Cells; Imidazoles; Indoles; Isoindoles; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Microcirculation; Muscle, Smooth, Vascular; Organ Culture Techniques; Phenylephrine; Piperazines; Quinolizines; Quinoxalines; Raynaud Disease; Receptors, Adrenergic, alpha-2; Scleroderma, Systemic; Skin; Tail; Vasoconstriction | 2000 |
Noradrenergic modulation of serotonin release in rat dorsal and median raphé nuclei via alpha(1) and alpha(2A) adrenoceptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Desipramine; Dexmedetomidine; Electric Stimulation; Electrophysiology; Imidazoles; In Vitro Techniques; Indoles; Isoindoles; Isoquinolines; Male; Norepinephrine; Phenylephrine; Piperazines; Prazosin; Raphe Nuclei; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Serotonin | 2001 |